Institutional shares held 307
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap $54.6M
29,518,200 Shares Out.
Institutional ownership 0.0%
# of Institutions 1

Quarterly Institutional Activity in DNAY

Shares Bought
Shares Sold
View Transactions

Latest Institutional Activity in DNAY

Top Purchases

Q1 2024
Ubs Group Ag Shares Held: 42.8K ($79.1K)
Q1 2024
Df Dent & CO Inc Shares Held: 20K ($37K)
Q1 2024
Tower Research Capital LLC (Trc) Shares Held: 3.11K ($5.74K)
Q1 2024
Qube Research & Technologies LTD Shares Held: 404 ($747)
Q1 2024
Royal Bank Of Canada Shares Held: 127 ($235)

Top Sells

Q1 2024
Millennium Management LLC Shares Held: 232K ($430K)
Q1 2024
Simplex Trading, LLC Shares Held: 100 ($185)
Q1 2024
Black Rock Inc. Shares Held: 24.8K ($45.9K)
Q1 2024
Bank Of America Corp Shares Held: 6K ($11.1K)
Q4 2023
Bridgeway Capital Management, LLC Shares Held: 67K ($124K)

About DNAY

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.


Insider Transactions at DNAY

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
330K Shares
From 11 Insiders
Grant, award, or other acquisition 330K shares
Sell / Disposition
19.3K Shares
From 4 Insiders
Payment of exercise price or tax liability 19.3K shares

Track Institutional and Insider Activities on DNAY

Follow Codex DNA, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNAY shares.

Notify only if

Insider Trading

Get notified when an Codex Dna, Inc. insider buys or sells DNAY shares.

Notify only if

News

Receive news related to Codex DNA, Inc.

Track Activities on DNAY